PRELIMINARY AGENDA

Breakfast / Networking

Welcoming Remarks
Yanhong Lin, Managing Partner, CTIC Capital
Mike Guerra, President and CEO, California Life Sciences Association
Steve Karp, Executive Director, California Life Sciences Institute

Keynote and Fireside Chat: CRISPR Technology and the Future of Genome Editing
Jennifer Doudna, Professor, UC Berkeley

Keynote: Precisely Practicing Medicine Using Ten Trillion Points of Data
Atul Butte, Professor, UCSF

Panel Discussion: Novel Drug and Therapy Development
Kevin Chen, Founding Partner, BioTrack Capital
Andrew Lee, Founder and Managing Director, StartX Med
Nils Lonberg, Venture Partner, Canaan Partners
Hongbo Lu, Managing Partner, Lilly Asia Ventures
Stella Xu, Managing Director, Quan Capital

Panel Discussion: The Age of the Cross-Border Collaborations – Opportunities and Challenges
Erdong Hua, Partner, 6 Dimensions Capital
Nisa Leung, Managing Partner, Qiming Ventures
Kevin Xie, Chief Representative of Fosun US
James Zhang, Partner, IDG Capital
James Zhao, Founding Partner, LYFE Capital

Company Presenting – Group 1
BridGene Biosciences
Ping Cao, Co-founder and CEO, BridGene Biosciences
Ming Li, Managing Partner, TF Capital

Travera
Clifford Reid, Founding CEO, Travera
Di Liu, Partner, Cowin Venture

ONL Therapeutics, Inc.
David Esposito, CEO, ONL Therapeutics
Lin Ni, Managing Director, State Development and Investment Corporation (SDIC)

Special Session: Exit Opportunities for China-focused Healthcare and BioPharma Companies in PRC, HK and US and CFIUS Update
Hosted by Wilson Sonsini Goodrich & Rosati
Joshua Gruenspecht, Partner-Elect, Regulatory and Compliance
Dan Ouyang, Partner, Corporate
Karen Wong, Senior Of Counsel

Keynote: Immunology and the Future of Medicine
Mark Davis, Professor, Stanford University

Panel Discussion: Transformative Technologies: Disruptive Diagnostic Tools augmented by Artificial Intelligence
Atul Butte, Professor, UCSF
Feng Han, Partner, Pagoda Capital Partners
Nicolas Roelofs, Partner, BioPath Ventures
Lin Wu, Vice President, Global Head of Assay and Platform Development, Roche
Ruilin Zhao, Partner, CD Capital

Company Presenting – Group 2
Insilico Medicine Inc
Alex Zhavoronkov, Founder，Insilico Medicine
Jeffry Wu, Managing Director, Milestone Capital

Quantapore
Martin Huber, Co-founder and CEO, Quantapore
Di Liu, Partner, Cowin Venture

RootPath
Xi Chen, Co-founder and CEO, RootPath
Hai Mi, Founding Managing Partner, Panacea Ventures

BioBeats
David Plans, Co-founder and CEO, BioBeats
Jun Hou, Managing Director, Fosun Private Equity

Panel Discussion: Dynamics of Entrepreneurship and Investments in China
Cheng Liu, CEO, Eureka Therapeutics
Xiaobo Lu, Partner, Sequoia Capital China
Victor Shi, Chairman, BayHelix, and CEO, Adicon Clinical Laboratories Inc
Jonathan Wang, Venture Partner, OrbiMed
Guo-Liang Yu, Global CEO, Apollomics and Venture Partner, OrbiMed

Company Presenting – Group 3
Towards Accelerated Medical Innovation
Jeff Karp, Professor of Medicine, Brigham and Women’s Hospital, Harvard Medical School

Kazia Therapeutics Limited
James Garner, CEO and Managing Director, Kazia Therapeutics
Michelle Chen, VP & Head of Corporate Development, WuXi Biologics

Boundless Bio
Scott Moorefield, CBO, Boundless Bio
Fei Qi, Director, Legend Capital

GreenBone Ortho srl
Lorenzo Pradella, Co-founder and CEO, GreenBone Ortho Srl
Stephen Chan, Investment Director, Co-High

General Automation Lab Technologies Inc.
Peter Christey, Co-founder and CEO, GATL
Jeffry Wu, Managing Director, Milestone Capital

Bionetix Therapeutics
Doo Young Jung, Founder and CEO, Bionetix Therapeutics
Michelle Chen, VP & Head of Corporate Development, WuXi Biologics

Cerecin
Charles Stacey, President and CEO， Cerecin
Stephen Chan, Investment Director, Co-High

Aleta Biotherapeutics
Mark Leuchtenberger, Executive Chairman, Aleta Biotherapeutics
Tianhong Xu, Founding Partner, Virtus Inspire Ventures

Cocktail Reception and Networking